🚀 VC round data is live in beta, check it out!
- Public Comps
- Ashland
Ashland Valuation Multiples
Discover revenue and EBITDA valuation multiples for Ashland and similar public comparables like Saudi Kayan, Huntsman, Quaker Houghton, Saudi Industrial Investment Group and more.
Ashland Overview
About Ashland
Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.
Founded
2016
HQ

Employees
2.9K
Website
Sectors
Financials (LTM)
EV
$4B
Valuation Multiples
Start free trialAshland Financials
Ashland reported last 12-month revenue of $2B and EBITDA of $396M.
In the same LTM period, Ashland generated $610M in gross profit, $396M in EBITDA, and $164M in net income.
Revenue (LTM)
Ashland P&L
In the most recent fiscal year, Ashland reported revenue of $2B and EBITDA of ($511M).
Ashland is unprofitable as of last fiscal year, with gross margin of 30%, EBITDA margin of (28%), and net margin of (46%).
Financial data powered by Morningstar, Inc.
Ashland Stock Performance
Ashland has current market cap of $2B, and enterprise value of $4B.
Market Cap Evolution
Ashland's stock price is $53.26.
Ashland share price increased by 7.6% in the last year.
Ashland has an EPS (earnings per share) of $-18.45.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $2B | 8.4% | — | -14.6% | 7.6% | $-18.45 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAshland Valuation Multiples
Ashland trades at 1.9x EV/Revenue multiple, and 9.0x EV/EBITDA.
EV / Revenue (LTM)
Ashland Financial Valuation Multiples
As of May 1, 2026, Ashland has market cap of $2B and EV of $4B.
Ashland has a P/E ratio of 14.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Ashland Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Ashland Margins & Growth Rates
In the most recent fiscal year, Ashland reported gross margin of 30%, EBITDA margin of (28%), and net margin of (46%).
Ashland Margins
Ashland Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Ashland Operational KPIs
Ashland's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.2M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Ashland Competitors
Ashland competitors include Saudi Kayan, Huntsman, Quaker Houghton, Saudi Industrial Investment Group, Orbia, Ingevity, Zeon, Abu Qir Fertilizers, MOPCO and Turpaz Industries.
Most Ashland public comparables operate across Chemicals.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.1x | 2.1x | 24.3x | 17.9x | |||
| 0.7x | 0.7x | 12.4x | 14.1x | |||
| 1.6x | 1.6x | 21.3x | 10.2x | |||
| — | — | (127.4x) | (516.3x) | |||
| 0.9x | 0.9x | 6.2x | 6.0x | |||
| 3.3x | 3.3x | 93.0x | 9.8x | |||
| 0.7x | 0.8x | 5.9x | 6.4x | |||
| 3.1x | 1.9x | 6.9x | 3.8x | |||
This data is available for Pro users. Sign up to see all Ashland competitors and their valuation data. Start Free Trial | ||||||
Ashland M&A Activity
Ashland has acquired 3 companies to date.
Last acquisition by Ashland was on January 19th 2021. Ashland acquired Schülke & Mayr (personal care unit) for $284M (EV/Revenue multiple of ).
Latest Acquisitions by Ashland
| Description | Schülke & Mayr personal care unit is a division of the Norderstedt-based Schülke & Mayr GmbH that manufactures and supplies disinfectants, antiseptics, preservatives, and biocides tailored for personal care formulations. Integrated within the broader Air Liquide-owned group since 2018, it focuses on skin-friendly antimicrobial agents used in hand sanitizers and body washes. The unit supports global personal care brands with products compliant to EU cosmetic regulations and supplies markets in Europe, Asia, and North America from German production facilities. | Pharmachem Laboratories is a New Jersey-based manufacturer and supplier of custom nutritional ingredients and process services. Serves natural products, food and beverage, and flavor and fragrance industries. Family of specialized divisions working together for integrated production capabilities. | Oil Can Henry’s is a Portland-headquartered chain of quick-lube service centers spanning Arizona, California, Colorado, Idaho, Minnesota, Oregon, and Washington. The company maintains 82 locations offering oil changes, fluid top-offs, and visual inspections without appointments. Oil Can Henry’s emphasizes eco-friendly practices with waste oil recycling programs. Founded in 1972, it expands through new builds in existing states, prioritizing customer convenience and technician training. |
| HQ Country | |||
| HQ City | Norderstedt | Kearny, NJ | Portland, OR |
| Deal Date | 19 Jan 2021 | 17 Apr 2017 | 1 Feb 2016 |
| Valuation | $284M | $660M | $72M |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Ashland acquisitions and their M&A valuation multiples. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Ashland
| When was Ashland founded? | Ashland was founded in 2016. |
| Where is Ashland headquartered? | Ashland is headquartered in United States. |
| How many employees does Ashland have? | As of today, Ashland has over 2K employees. |
| Who is the CEO of Ashland? | Ashland's CEO is Guillermo Novo. |
| Is Ashland publicly listed? | Yes, Ashland is a public company listed on NYSE. |
| What is the stock symbol of Ashland? | Ashland trades under ASH ticker. |
| When did Ashland go public? | Ashland went public in 1950. |
| Who are competitors of Ashland? | Ashland main competitors include Saudi Kayan, Huntsman, Quaker Houghton, Saudi Industrial Investment Group, Orbia, Ingevity, Zeon, Abu Qir Fertilizers, MOPCO, Turpaz Industries. |
| What is the current market cap of Ashland? | Ashland's current market cap is $2B. |
| What is the current revenue of Ashland? | Ashland's last 12 months revenue is $2B. |
| What is the current revenue growth of Ashland? | Ashland revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Ashland? | Current revenue multiple of Ashland is 1.9x. |
| Is Ashland profitable? | Yes, Ashland is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Ashland? | Ashland's last 12 months EBITDA is $396M. |
| What is Ashland's EBITDA margin? | Ashland's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Ashland? | Current EBITDA multiple of Ashland is 9.0x. |
| What is the current FCF of Ashland? | Ashland's last 12 months FCF is $143M. |
| What is Ashland's FCF margin? | Ashland's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of Ashland? | Current FCF multiple of Ashland is 24.9x. |
| How many companies Ashland has acquired to date? | As of May 2026, Ashland has acquired 3 companies. |
| What was the largest acquisition by Ashland? | $660M acquisition of Pharmachem Laboratories on 17th April 2017 was the largest M&A Ashland has done to date. |
| What companies Ashland acquired? | Ashland acquired Pharmachem Laboratories, Schülke & Mayr (personal care unit), and Oil Can Henry’s. |
| In how many companies Ashland has invested to date? | Ashland hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Ashland
Lists including Ashland
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

